Motexafin gadolinium: a possible new radiosensitiser

By Rodrigus Patrick  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 7, 2003-07 ,pp. : 1205-1210

Informa Healthcare

Access to resources Recommend Favorite

Motexafin Gadolinium: Gadolinium (III) Texaphyrin, Gadolinium Texaphyrin, Gd-Tex, GdT2B2, PCI 0120

By Adis International Limited  

Drugs in R&D, Vol. 5, Iss. 1, 2004-01 ,pp. : 52-57

Adis International

Access to resources Recommend Favorite

Population pharmacokinetics and bioavailability of motexafin gadolinium (Xcytrin^®) in CD1 mice following intravenous and intraperitoneal injection

By GW Boswell   Miles DR   Thiemann PA   Mesfin M  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 281-289

Springer Publishing Company

Access to resources Recommend Favorite

Targeting Autophagy in the Brain: A Promising Approach?

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 10, Iss. 2, 2010-06 ,pp. : 158-168

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic treatment in breast-cancer patients with brain metastasis

By Arslan Cagatay   Dizdar Omer   Altundag Kadri  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1089-1100

Informa Healthcare

Access to resources Recommend Favorite